Expanded meanings:
- HT contraindicated: Issues such as vaginal bleeding, metastatic solid tumor, tumor without metastasis, angina pectoris, myocardial infarction, thrombosis. coagulated blood clotting disorder, liver disease.
- Caution required at HT initiation - Conditions requiring a cardiovascular or breast cancer evaluation before HT, current smoker, BMI overweight, family or personal history of breast cancer, history of migraine, diabetes, and elevated cholesterol/hyperlipidemia.
Citation formats
Interest in taking HT among women with VMS in Europe 2020
According to a survey carried out in five European countries in 2020, almost ** percent of women who were eligible for hormone therapy (HT) in Spain were adverse to taking the medication. Over a fifth of respondents in Germany said they were HT contraindicated which meant they were advised against using it due to certain conditions.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Elsevier. (June 23, 2022). Feelings towards receiving hormone therapy among those with VMS due to the menopause in France, Germany, Italy, Spain, and the UK as of 2020 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 28, 2026, from /statistics/1366300/interest-in-taking-ht-for-menopause-in-europe/
Elsevier. "Feelings towards receiving hormone therapy among those with VMS due to the menopause in France, Germany, Italy, Spain, and the UK as of 2020." Chart. June 23, 2022. ÌÇÐÄÆƽâ°æ. Accessed July 28, 2026. /statistics/1366300/interest-in-taking-ht-for-menopause-in-europe/
Elsevier. (2022). Feelings towards receiving hormone therapy among those with VMS due to the menopause in France, Germany, Italy, Spain, and the UK as of 2020. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 28, 2026. /statistics/1366300/interest-in-taking-ht-for-menopause-in-europe/
Elsevier. "Feelings towards Receiving Hormone Therapy among Those with Vms Due to The Menopause in France, Germany, Italy, Spain, and The Uk as of 2020." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 23 Jun 2022, /statistics/1366300/interest-in-taking-ht-for-menopause-in-europe/
Elsevier, Feelings towards receiving hormone therapy among those with VMS due to the menopause in France, Germany, Italy, Spain, and the UK as of 2020 ÌÇÐÄÆƽâ°æ, /statistics/1366300/interest-in-taking-ht-for-menopause-in-europe/ (last visited July 28, 2026)
Feelings towards receiving hormone therapy among those with VMS due to the menopause in France, Germany, Italy, Spain, and the UK as of 2020 [Graph], Elsevier, June 23, 2022. [Online]. Available: /statistics/1366300/interest-in-taking-ht-for-menopause-in-europe/
